Arthritis Research Program
The Arthritis Research Program funds innovative research to advance prevention, diagnosis, and treatment of all forms of arthritis, aiming to improve clinical care and patient outcomes.
Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026: Pre-application / preproposal deadline (projected) | October 2026: Full application submission deadline by invitation only (projected)
Funding Amounts: Clinical Research Award: up to $1.3M (Level 1) or $3.25M (Level 2)/4 yrs; Translational Research Award: up to $800K/3 yrs (total costs, incl. direct & indirect)
Summary: Supports innovative research to improve prevention, diagnosis, and treatment of arthritis, aiming to enhance health outcomes for those affected.
Key Information: Pre-application required; full proposals by invitation only.
Description
The Arthritis Research Program (ATRP), funded by the Defense Health Agency and managed by the Congressionally Directed Medical Research Programs (CDMRP), supports innovative, high-impact research with clinical relevance to optimize the health and well-being of individuals affected by arthritis. The program focuses on prevention, early diagnosis, treatment, and mitigation of arthritis progression and burden. Research is encouraged on predictive factors for disease onset, development of prevention technologies or solutions, and evaluation of interventions addressing the multifactorial impacts of arthritis, including pain, function, psychosocial factors, comorbidities, and pathological burden. The ATRP aims to generate clinically useful evidence and accelerate translation of findings into practical solutions for arthritis care.
